Cover Image

Relaxin-2 Does Not Ameliorate Nephropathy in an Experimental Model of Type-1 Diabetes

Background/Aims: In diabetic nephropathy (DN), the current angiotensin-II-blocking pharmacotherapy is frequently failing. For diabetic cardiomyopathy (DC), there is no specific remedy available. Relaxin-2 (Rlx) - an anti-fibrotic, anti-inflammatory, and vasoprotecting peptide - is a candidate drug f...

Full description

Saved in:

Bibliographic Details
Main Authors:	Thomas Bernd Dschietzig (Author), Katharina Krause-Relle (Author), Maud Hennequin (Author), Karoline von Websky (Author), Jan Rahnenführer (Author), Jana Ruppert (Author), Hans Jürgen Grön (Author), Franz Paul Armbruster (Author), Ross A. D. Bathgate (Author), Joerg R. Aschenbach (Author), Wolf-Georg Forssmann (Author), Berthold Hocher (Author)
Format:	Book
Published:	Karger Publishers, 2015-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacokinetic and Pharmacodynamic Characteristics of Subcutaneously Applied PTH-1-37
by: Wolf-Georg Forssmann, et al.
Published: (2016)

Examination of relaxin and its receptors expression in pig gametes and embryos
by: Bathgate Ross A, et al.
Published: (2011)

Synthetic short-chain peptide analogues of H1 relaxin lack affinity for the RXFP1 receptor and relaxin-like bioactivity. Clues to a better understanding of relaxin agonist design
by: Annunziata D'Ercole, et al.
Published: (2022)

Modeling of Oxidized PTH (oxPTH) and Non-oxidized PTH (n-oxPTH) Receptor Binding and Relationship of Oxidized to Non-Oxidized PTH in Children with Chronic Renal Failure, Adult Patients on Hemodialysis and Kidney Transplant Recipients
by: Berthold Hocher, et al.
Published: (2013)

Plasma Kynurenine Predicts Severity and Complications of Heart Failure and Associates with Established Biochemical and Clinical Markers of Disease
by: Thomas Bernd Dschietzig, et al.
Published: (2019)

Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes
by: Hooi Hooi Ng, et al.
Published: (2018)

RELAXIN AND IMMUNE FACTORS AS PREDICTORS OF BIOLOGICAL PREPARATION FOR LABOUR
by: N.O. Shcherbina, et al.
Published: (2020)

Biology of primate relaxin: A paracrine signal in early pregnancy?
by: Hayes Eric S
Published: (2004)

Relaxin receptors and nitric oxide synthases: search for the missing link
by: Bani Daniele, et al.
Published: (2003)

Relaxin treatment stimulates the differentiation of mesenchymal stem cells into osteoblasts
by: Lina M. Escobar, et al.
Published: (2023)

Expression and Characterization of Relaxin Family Peptide Receptor 1 Variants
by: David Speck, et al.
Published: (2022)

Trends in serum relaxin concentration among elite collegiate female athletes
by: Jason L Dragoo, et al.
Published: (2011)

Relaxin-3 Innervation From the Nucleus Incertus to the Parahippocampal Cortex of the Rat
by: Cristina García-Díaz, et al.
Published: (2021)

Immunoexpression of the relaxin receptor LGR7 in breast and uterine tissues of humans and primates
by: Milde-Langosch Karin, et al.
Published: (2003)

Pre-Interventional Kynurenine Predicts Medium-Term Outcome after Contrast Media Exposure Due to Coronary Angiography
by: Christoph Reichetzeder, et al.
Published: (2017)

<it>In vitro </it>effects of relaxin on gene expression in porcine cumulus-oocyte complexes and developing embryos
by: Willard Scott T, et al.
Published: (2011)

Relaxin inhibits cardiac fibrosis and endothelial–mesenchymal transition via the Notch pathway
by: Zhou X, et al.
Published: (2015)

Relaxin inhibits cardiac fibrosis and endothelial–mesenchymal transition via the Notch pathway [Corrigendum]
by: Zhou X, et al.
Published: (2017)

Relaxin-3/RXFP3 networks: an emerging target for the treatment of depression and other neuropsychiatric diseases?
by: Craig M Smith, et al.
Published: (2014)

Comparative distribution of relaxin-3 inputs and calcium-binding protein-positive neurons in rat amygdala
by: Fabio N Santos, et al.
Published: (2016)

Involvement of the Nucleus Incertus and Relaxin-3/RXFP3 Signaling System in Explicit and Implicit Memory
by: Isis Gil-Miravet, et al.
Published: (2021)

Relaxin/insulin-like family peptide receptor 4 (Rxfp4) expressing hypothalamic neurons modulate food intake and preference in mice
by: Jo E. Lewis, et al.
Published: (2022)

GABAergic Neurons in the Rat Medial Septal Complex Express Relaxin-3 Receptor (RXFP3) mRNA
by: Hector Albert-Gascó, et al.
Published: (2018)

Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1
by: Anita A. Pinar, et al.
Published: (2020)

Comparison of sGC activator and sGC stimulator in 5/6 nephrectomized rats on high-salt-diet
by: Xin Chen, et al.
Published: (2024)

Relaxin family peptide receptors Rxfp1 and Rxfp2: mapping of the mRNA and protein distribution in the reproductive tract of the male rat
by: Porto Catarina S, et al.
Published: (2007)

Relaxin peptides reduce cellular damage in cultured brain slices exposed to transient oxygen-glucose deprivation: an effect mediated by nitric oxide
by: Nicholas P. DeAdder, et al.
Published: (2021)

Relaxin-encapsulated polymeric metformin nanoparticles remodel tumor immune microenvironment by reducing CAFs for efficient triple-negative breast cancer immunotherapy
by: Hongyan Zhang, et al.
Published: (2023)

Effects of swimming exercise and RLN2 induction on relaxin levels, MMP-13, TGFβ expression in the pubic cartilage of pregnant rats
by: Ika Oktaviani, et al.
Published: (2022)

Chronic Exposure to Cigarette Smoke Affects the Ileum and Colon of Guinea Pigs Differently. Relaxin (RLX-2, Serelaxin) Prevents Most Local Damage
by: Chiara Traini, et al.
Published: (2022)

The SGLT2 Inhibitor Empagliflozin Might Be a New Approach for the Prevention of Acute Kidney Injury
by: Chang Chu, et al.
Published: (2019)

Human Relaxin-2 (Serelaxin) Attenuates Oxidative Stress in Cardiac Muscle Cells Exposed In Vitro to Hypoxia-Reoxygenation. Evidence for the Involvement of Reduced Glutathione Up-Regulation
by: Silvia Nistri, et al.
Published: (2020)

THE ANTI-FIBROTIC ACTIONS OF RELAXIN ARE MEDIATED THROUGH A NO-sGC-cGMP-DEPENDENT PATHWAY IN RENAL MYOFIBROBLASTS IN VITRO AND ENHANCED BY THE NO DONOR, DIETHYLAMINE NONOATE
by: Chao eWang, et al.
Published: (2016)

Plasma ET-1 Concentrations are Elevated in Patients with Hypertension - Meta-Analysis of Clinical Studies
by: Mei Xu, et al.
Published: (2017)

Plasma ET-1 Concentrations Are Elevated in Pregnant Women with Hypertension -Meta-Analysis of Clinical Studies
by: Yong-Ping Lu, et al.
Published: (2017)

Transthyretin Predicts Cardiovascular Outcome In Hemodialysis Patients With Diabetes Mellitus Type 2
by: Andrea Henze, et al.
Published: (2012)

Endostatin in Renal and Cardiovascular Diseases
by: Mei Li, et al.
Published: (2021)

Global Overexpression of ET-1 Decreases Blood Pressure - A Systematic Review and Meta-Analysis of ET-1 Transgenic Mice
by: Yong Ping Lu, et al.
Published: (2016)

Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data
by: Hasford Joerg, et al.
Published: (2011)

Beyrouth, une ville d'Orient marquée par l'Occident
by: Helmut Ruppert
Published: (1999)